Perspective Therapeutics Files 8-K

Ticker: CATX · Form: 8-K · Filed: Apr 11, 2025 · CIK: 728387

Sentiment: neutral

Topics: sec-filing, 8-k, regulatory-update

TL;DR

PTX filed an 8-K on 4/11. No major news yet, just procedural.

AI Summary

Perspective Therapeutics, Inc. filed an 8-K on April 11, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington. This filing does not appear to contain specific financial figures or details about the 'other events' reported.

Why It Matters

This 8-K filing indicates that Perspective Therapeutics, Inc. has made a regulatory submission to the SEC, which may contain important updates about the company's operations or financial status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for 'Other Events' and financial statements, without immediate disclosed material impact.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported in this 8-K filing?

The filing indicates 'Other Events' as an item, but the provided text does not detail the specific nature of these events.

When was Perspective Therapeutics, Inc. formerly known as Isoray, Inc.?

The company was formerly known as Isoray, Inc., with a date of name change listed as December 31, 2018.

Where is Perspective Therapeutics, Inc. headquartered?

Perspective Therapeutics, Inc. is headquartered in Seattle, Washington, with its business address at 2401 Elliott Avenue, Suite 320.

What is the Standard Industrial Classification (SIC) code for Perspective Therapeutics, Inc.?

The SIC code for Perspective Therapeutics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What is the Commission File Number for Perspective Therapeutics, Inc.?

The Commission File Number for Perspective Therapeutics, Inc. is 001-33407.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 regarding Perspective Therapeutics, Inc. (CATX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing